DBV EBITDA Margin from 2010 to 2024
| DBVT Stock | USD 0.66 0.02 2.94% |
Check DBV Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DBV main balance sheet or income statement drivers, such as Interest Expense of 754.8 K, Selling General Administrative of 28.6 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 53.9, Dividend Yield of 0.0024 or PTB Ratio of 1.23. DBV financial statements analysis is a perfect complement when working with DBV Technologies Valuation or Volatility modules.
DBV | EBITDA Margin |
About DBV Technologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include DBV Technologies income statement, its balance sheet, and the statement of cash flows. DBV Technologies investors use historical funamental indicators, such as DBV Technologies's EBITDA Margin, to determine how well the company is positioned to perform in the future. Although DBV Technologies investors may use each financial statement separately, they are all related. The changes in DBV Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DBV Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on DBV Technologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in DBV Technologies. Please read more on our technical analysis and fundamental analysis pages.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DBV Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DBV Technologies' short interest history, or implied volatility extrapolated from DBV Technologies options trading.
Pair Trading with DBV Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DBV Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBV Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with DBV Stock
| 0.76 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against DBV Stock
| 0.73 | OPT | Opthea | PairCorr |
| 0.69 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.67 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.64 | ELYM | Eliem Therapeutics | PairCorr |
| 0.62 | AVTE | Aerovate Therapeutics Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to DBV Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DBV Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DBV Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DBV Technologies to buy it.
The correlation of DBV Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DBV Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DBV Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DBV Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of DBV Technologies Correlation against competitors. For more information on how to buy DBV Stock please use our How to Invest in DBV Technologies guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for DBV Stock analysis
When running DBV Technologies' price analysis, check to measure DBV Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV Technologies is operating at the current time. Most of DBV Technologies' value examination focuses on studying past and present price action to predict the probability of DBV Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DBV Technologies' price. Additionally, you may evaluate how the addition of DBV Technologies to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is DBV Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DBV Technologies. If investors know DBV will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DBV Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.38) | Revenue Per Share 0.0825 | Quarterly Revenue Growth 0.144 | Return On Assets (0.22) | Return On Equity (0.43) |
The market value of DBV Technologies is measured differently than its book value, which is the value of DBV that is recorded on the company's balance sheet. Investors also form their own opinion of DBV Technologies' value that differs from its market value or its book value, called intrinsic value, which is DBV Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DBV Technologies' market value can be influenced by many factors that don't directly affect DBV Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DBV Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if DBV Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DBV Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.